Researchers say immune cells that normally rush in to protect the eyes from infection might actually be disrupting moisturising glands and causing dry eye disease (DED). This finding, from a team led by Duke Eye Center in the US, could lead to more effective therapies for DED instead of treatments that only address symptoms.
“This study shows that some forms of Meibomian gland dysfunction (MGD) are inflammatory diseases, and our studies in mice confirm what we see in the tears of people with blocked glands,” said Duke ophthalmologist Dr Preeya Gupta, a co-author of the study published in the journal Science Translational Medicine. “This pathway may be a new target for therapeutic agents to help treat patients suffering from DED and MGD.”
Whether brought on by allergies, contact lenses or a tendency to blink less while using computers and other electronic devices, DED is linked to blockages in the Meibomian glands of the eyelid. The Duke researchers found that immune cells called neutrophils, which rush in to relieve inflamed eyes, might also be disrupting the moisturizing glands.
In some people, MGD is a visible condition, marked by small off-white beads along the eyelid that look like plugged pores or whiteheads. For many others, the MGD is undetected and undiagnosed. “In addition to providing new treatment strategies, the presence of neutrophils in the eye could provide a biomarker to detect the disease or measure its severity,” said the study’s senior author, Dr Daniel Saban.
Neutrophils are found in many tissues of the body. For example, when pathogens such as bacteria make their way into the gut, commanders of the immune system known as T cells identify the invader and help recruit neutrophils to fight the battle.







